Top

Published in:

Open Access 01-11-2010 | Correspondence

Statistical analysis plan of PROWESS SHOCK study

Authors: B. Taylor Thompson, V. Marco Ranieri, Simon Finfer, Philip S. Barie, Jean-Francois Dhainaut, Ivor S. Douglas, Bengt Gårdlund, John C. Marshall, Andrew Rhodes, The PROWESS SHOCK Steering Committee

Published in: Intensive Care Medicine | Issue 11/2010

Excerpt

Dear Editor, …

Available only for authorised users

Finfer S, Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Gårdlund B, Marshall JC, Rhodes A (2008) Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 34:1935–1947CrossRefPubMed

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 36:296–327

http://www.fda.gov/downloads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM201790.pdf

Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC (2010) The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36:222–231CrossRefPubMed

Delaney A, Angus DC, Bellomo R, Cameron P, Cooper DJ, Finfer S, Harrison DA, Huang DT, Myburgh JA, Peake SL, Reade MC, Webb SA, Yealy DM, Resuscitation in Sepsis Evaluation (ARISE), Protocolized Care for Early Septic Shock (ProCESS) Investigators, Protocolised Management In Sepsis (ProMISe) Investigators (2008) Bench-to-bedside review: the evaluation of complex interventions in critical care. Crit Care 12:210CrossRefPubMed

Bernard GR et al (2007) TAK-242 Treatment for severe sepsis: a randomized controlled trial. Crit Care Med 35:A264(946)

Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM, Eritoran Sepsis Study Group (2010) Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med 38:72–83CrossRefPubMed

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide evaluation in severe sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis [comment]. N Engl J Med 344:699–709CrossRefPubMed

Finfer S, Bellomo R (2009) Why publish statistical analysis plans? Crit Care Resusc 11:5–6PubMed

Title: Statistical analysis plan of PROWESS SHOCK study
Authors: B. Taylor Thompson
V. Marco Ranieri
Simon Finfer
Philip S. Barie
Jean-Francois Dhainaut
Ivor S. Douglas
Bengt Gårdlund
John C. Marshall
Andrew Rhodes
The PROWESS SHOCK Steering Committee
Publication date: 01-11-2010
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 11/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-010-1977-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Statistical analysis plan of PROWESS SHOCK study

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2010

Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients

Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock

Where is the pacemaker lead?

The “koala stress syndrome” and adrenal responsiveness in the critically ill

Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals

Refractory agitation as a marker for pediatric delirium in very young infants at a pediatric intensive care unit